Figure 2From: Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival studyCancer treatment and prognosis. Patients treated with combined treatment had a better disease-free time (A), disease-specific-survival (B), as well as overall survival (C).Back to article page